Brighter (OM:BRIG) - Hisse Senedi Fiyatı, Haberler ve Analizler

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

BRIG Stoklara Genel Bakış

Brighter AB (publ), a health-tech company, develops solutions for the treatment of chronic condition in Sweden and internationally. Daha fazla detay

BRIG temel anali̇z
Kar Tanesi Skoru
Değerleme	2/6
Gelecekteki Büyüme	0/6
Geçmiş Performans	0/6
Finansal Sağlık	4/6
Temettüler	0/6

Risk Analizi

Hissedarlar geçen yıl önemli ölçüde sulandırıldı

1 yıldan az nakit akışı var

Kazançlar son 5 yılda yılda 42% oranında azaldı

Anlamlı bir piyasa değeri yok ( SEK23M )

+ 2 daha fazla risk

Brighter AB (publ) Rakipler

Carbiotix

NGM:CRBX

SEK 34.6m

Medfield Diagnostics

NGM:MEDF

SEK 23.6m

Zenicor Medical Systems

NGM:ZENI

SEK 26.9m

Fluicell

OM:FLUI

SEK 28.4m

Fiyat Geçmişi ve Performans

için tüm zamanların en yüksek seviyelerinin, değişikliklerin ve fiyat düşüşlerinin özeti Brighter
Tarihsel hisse senedi fiyatları
Güncel Hisse Fiyatı	SEK 0.017
52 Haftanın En Yüksek Seviyesi	SEK 0.58
52 Haftanın En Düşük Seviyesi	SEK 0.0069
Beta	1.62
11 Aylık Değişim	-47.19%
3 Aylık Değişim	-78.33%
1 Yıllık Değişim	-95.98%
33 Yıllık Değişim	-99.81%
5 Yıllık Değişim	-99.84%
Halka arzdan bu yana değişim	-99.47%

Son Haberler & Güncellemeler

Recent updates

Brighter (STO:BRIG) Share Prices Have Dropped 77% In The Last Three Years

Jan 16

Brighter (STO:BRIG) May Not Be Profitable But It Seems To Be Managing Its Debt Just Fine, Anyway

Nov 22

Hissedar Getirileri

	BRIG	SE Medical Equipment	SE Pazar
7D	-55.5%	0.8%	0.7%
1Y	-96.0%	-4.3%	12.3%

Getiri vs. Endüstri: BRIG geçen yıl % -4.3 oranında getiri sağlayan Swedish Medical Equipment sektörünün gerisinde kaldı.

Getiri vs Piyasa: BRIG geçen yıl % 12.3 oranında getiri sağlayan Swedish Piyasasının altında performans gösterdi.

Fiyat Oynaklığı

Is BRIG's price volatile compared to industry and market?
BRIG volatility
BRIG Average Weekly Movement	91.4%
Medical Equipment Industry Average Movement	7.6%
Market Average Movement	5.5%
10% most volatile stocks in SE Market	11.4%
10% least volatile stocks in SE Market	3.3%

İstikrarlı Hisse Senedi Fiyatı: BRIG hisse senedi fiyatı son 3 aydır dalgalı bir seyir izliyor.

Zaman İçindeki Volatilite: BRIG 'nin haftalık oynaklığı geçtiğimiz yıl boyunca 46% dan 91% a yükseldi.

Şirket Hakkında

Kuruldu	Çalışanlar	CEO	Web sitesi
2007	57	Erik Lissner	brighter.se

Brighter AB (publ) Temel Bilgiler Özeti

Brighter'un kazançları ve gelirleri piyasa değeriyle nasıl karşılaştırılır?
BRIG temel i̇stati̇sti̇kler
Piyasa değeri	SEK 23.21m
Kazançlar(TTM)	-SEK 183.70m
Gelir(TTM)	SEK 33.03m

0.7x

P/S Oranı

-0.1x

F/K Oranı

BRIG aşırı değerli mi?

Gerçeğe Uygun Değer ve değerleme analizine bakınız

Kazanç ve Gelir

En son kazanç raporundan temel karlılık istatistikleri (TTM)
BRIG gelir tablosu (TTM)
Gelir	SEK 33.03m
Gelir Maliyeti	SEK 10.88m
Brüt Kâr	SEK 22.15m
Diğer Giderler	SEK 205.85m
Kazançlar	-SEK 183.70m

Son Raporlanan Kazançlar

Jun 30, 2022

Sonraki Kazanç Tarihi

Nov 29, 2022

Hisse başına kazanç (EPS)	-0.13
Brüt Marj	67.05%
Net Kâr Marjı	-556.20%
Borç/Özkaynak Oranı	1.7%

BRIG uzun vadede nasıl bir performans gösterdi?

Geçmiş performansı ve karşılaştırmayı görün

This company listing is no longer active

BRIG Stoklara Genel Bakış

Risk Analizi

Brighter AB (publ) Rakipler

NGM:CRBX

SEK 34.6m

NGM:MEDF

SEK 23.6m

NGM:ZENI

SEK 26.9m

OM:FLUI

SEK 28.4m

Fiyat Geçmişi ve Performans

Son Haberler & Güncellemeler

Nasdaq Stockholm AB Decides to Delist the Shares and Equity Rights of Brighter AB

Nasdaq Stockholm imposes a fine on Brighter AB (publ)

Brighter AB (Publ) Applies for Corporate Restructuring in Bid for Longer-Term Financing

Brighter AB (publ) Announces Executive Changes

Brighter AB (publ) to Report Fiscal Year 2022 Results on Apr 13, 2023

Second quarter 2022 earnings released: kr0.05 loss per share (vs kr0.21 loss in 2Q 2021)

Recent updates

Nasdaq Stockholm AB Decides to Delist the Shares and Equity Rights of Brighter AB

Nasdaq Stockholm imposes a fine on Brighter AB (publ)

Brighter AB (Publ) Applies for Corporate Restructuring in Bid for Longer-Term Financing

Brighter AB (publ) Announces Executive Changes

Brighter AB (publ) to Report Fiscal Year 2022 Results on Apr 13, 2023

Second quarter 2022 earnings released: kr0.05 loss per share (vs kr0.21 loss in 2Q 2021)

Brighter AB (Publ.) Announces its Actiste® Receives Telecommunication Type Approval in the United Arab Emirates

High number of new and inexperienced directors

Brighter AB (publ) Receives Final Approvals for Pilot Research with Insulin-Treated Diabetes Patients in the UAE

High number of new and inexperienced directors

Brighter's Interim CEO Erik Lissner Takes Permanent Role as the Company CEO

Brighter AB Announces Actiste®, for the First Time, Is Prescribed to A Patient Living with Diabetes in Qatar

700Brighter AB Announces Actiste, for the First Time, Is Prescribed to A Patient Living with Diabetes in Qatar

Brighter AB (Publ) Announces Appointment of Johnny Ludvigsson as Board Member

Brighter AB (publ) Announces First Patient Recruited for the Actiste Study in the United Kingdom

First quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

High number of new and inexperienced directors

Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behind

Brighter AB (Publ) Announces Launch and Commercial Availability of its Actiste® Service, Aiming to Improve the Quality of Life for People Living with Diabetes in Qatar

Full year 2021 earnings: EPS and revenues exceed analyst expectations

Brighter AB (publ) to Report Fiscal Year 2021 Results on Apr 13, 2022

Brighter AB (publ) to Report Q3, 2022 Results on Nov 09, 2022

Brighter AB (publ), Annual General Meeting, May 05, 2022

Brighter AB (publ) has completed a Composite Units Offering in the amount of SEK 117.093404 million.

Brighter AB (publ) announces positive results for Actiste®

A shareholder of Blodtrycksdoktorn AB entered into an agreement to acquire an unknown stake in Blodtrycksdoktorn AB from Brighter AB (publ) (OM:BRIG) for SEK 5 million.

Beijing AddLife AB (publ) (OM:ALIF B) acquired Camanio AB from Brighter AB (publ) (OM:BRIG) for SEK 65 million.

Third quarter 2021 earnings released: kr0.20 loss per share (vs kr0.18 loss in 3Q 2020)

Brighter's Actiste Receives Final Outstanding Approval in Qatar

Interim Chief Financial Officer Julie Silber has left the company

Second quarter 2021 earnings released: kr0.20 loss per share (vs kr0.27 loss in 2Q 2020)

Brighter's Actiste Receives Telecommunication Approval in Qatar

Brighter's Actiste Mini Receives Telecommunication Approval in Qatar

Compatibility with New Insulins Opens Up New Market Opportunities for Brighter's Actiste

Brighter AB (Publ) Launches Innovative Pilot Project with Tomelilla Municipality

Brighter AB (Publ) Provides Revenue Guidance for the Year 2021

Brighter AB (Publ) Makes Progress with the User Experience Test of the Diabetes Management Solution Actiste

First quarter 2021 earnings released: kr0.20 loss per share (vs kr0.19 loss in 1Q 2020)

Brighter AB (Publ) Announces the Patent to Safely Combine MDD and IVDD Functionality into One Unit

Revenue and earnings beat expectations

Full year 2020 earnings released: kr1.04 loss per share (vs kr1.06 loss in FY 2019)

Brighter AB (publ) to Report Q4, 2021 Results on Feb 20, 2022

Brighter Signs 5-Year Distribution Agreement for Actiste in Qatar

New 90-day low: kr1.31

Brighter AB (publ) Announces CEO Changes

New 90-day low: kr1.60

Brighter (STO:BRIG) Share Prices Have Dropped 77% In The Last Three Years

Brighter AB (publ) Announces Diabetes Management Devices Actiste and Actiste Mini Receives Market Approval in Thailand

Brighter AB (publ) Announces Clarification of Information Regarding Agreements for Nigeria and Ghana

Brighter AB (publ) Signs 5-Year Agreement with Wssonlines Nigeria Ltd and Receives Initial Order for Actiste® Worth Eur 2.3 Million in Nigeria

New 90-day low: kr2.15

Brighter AB (publ)'s Actiste® Mini Receives Market Approval in the Kingdom of Saudi Arabia

Brighter AB (Publ) Announces Nomination Committee for the AGM 2021

Brighter (STO:BRIG) May Not Be Profitable But It Seems To Be Managing Its Debt Just Fine, Anyway

Brighter AB (publ) Announces Executive Changes

New 90-day high: kr3.50

Brighter's Pioneering Diabetes Management Solution Actiste® Receives Market Approval in the United Arab Emirates

Third quarter 2020 earnings released: kr0.16 loss per share

Brighter AB (Publ) Announces Actiste Device and Its Associated Digital Platform Received Market Approval from the Saudi Food and Drug Authority